Valeas Capital Partners, a recently launched investor-operator focused firm led by Ed Woiteshek and Rob Little (former Hellman & Friedman colleagues) has led a USD70 million Series B equity financing round in Well Dot (Well), a consumer-focused health improvement platform that combines leading-edge artificial intelligence, advanced behavioural economic techniques and on-demand human guidance.
A new investor group of 12 prominent CEOs and senior managing partners at top-tier private equity firms also joined the financing, while existing investors General Catalyst and partners of Hellman & Friedman also participated. The company previously raised USD40 million in a Series A financing in 2020 and USD25 million in seed funding in 2019.
The latest funding gives Well the capital to continue to scale its operations and expand its industry-leading platform to deliver enhanced functionality and improved health to an increasing number of members.
